Embedded Files
Hawksworth, J.I., Kirkby-Geddes, E., Thom, S., et al. (2026). "Lewy Bodies Are Not Associated With Neuronal or Synaptic Loss in Dementia With Lewy Bodies." Neuropathology and Applied Neurobiology 52(3): e70085. DOI:10.1111/nan.70085
Markiewicz, P.J., Thompson, G., Wardlaw, J.M., et al. (2026). "The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network." European Journal of Nuclear Medicine and Molecular Imaging. DOI: 10.1007/s00259-026-07885-4
Harrison, J.R., Robertson, A., Tang, S.L., et al. (2026). "Automating collateral histories in dementia: Development and proof‑of‑concept evaluation of the LUMEN conversational AI." INTERNATIONAL PSYCHOGERIATRICS: 100221. DOI:10.1016/j.inpsyc.2026.100221
Ueda, M., Erskine, D., Thomas, A., et al. (2026). "Association between angiotensin receptor blocker use and postmortem dementia pathology: analysis of the UK Brain Banks Network dataset." BMJ Neurology Open 8(1): e001342. DOI: 10.1136/bmjno-2025-001342
Donaghy, P.C., Greenfinch, G., Petrides, G., et al. (2026). "Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies." Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 18(1): e70296. DOI:10.1002/dad2.70296
Hasoon, J., Hamilton, C.A., Firbank, M., et al. (2026). "Multimodal biomarkers to predict dementia-free survival and cognitive decline in mild cognitive impairment with Lewy bodies." PARKINSONISM & RELATED DISORDERS 145: 108265. DOI:10.1016/j.parkreldis.2026.108265
Jakhar, D., Noce, G., Del Percio, C., et al. (2026). "Abnormal Resting-State EEG delta and alpha rhythms in Huntington’s and Alzheimer’s Diseases: An exploratory study." CLINICAL NEUROPHYSIOLOGY 184: 2111518. DOI:10.1016/j.clinph.2026.2111518
Hamilton, C.A., Gallagher, P., Donaghy, P.C., et al. (2026). "Subjective estimation of cognitive function in mild cognitive impairment: relationship with neurodegenerative and non-degenerative factors." PSYCHOLOGICAL MEDICINE 56: e19. DOI: 10.1017/S0033291725102997
Atewogboye, O., Taylor, J. and Harrison, J. (2025). "Pharmacological strategies for managing dementia with Lewy bodies: an expert review of symptom-targeted care." Expert Review of Clinical Pharmacology 18(9): 645-653. DOI: 10.1080/17512433.2025.2562151
Colloby, S., Nitchingham, A., Richardson, S., et al. (2025). "Cerebral metabolic covariance in delirium: pattern response to symptomatic changes." ALZHEIMERS & DEMENTIA 21(12). DOI: 10.1002/alz.70993
Fullam, S., Harrison, J., Anderson, K., et al. (2025). "Dementia with Lewy bodies: a practical guide to clinical diagnosis and management." Practical Neurology. DOI: 10.1136/pn-2025-004745
Heller, N., Barrett, F., Buchborn, T., et al. (2025). "Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases." Schizophrenia Bulletin 51: S273-S291. DOI: 10.1093/schbul/sbaf068
Mummery, C., Rasmussen, J., Blackburn, D., et al. (2025). "Lecanemab appropriate use recommendations for clinical practice in the UK." Journal of Neurology Neurosurgery and Psychiatry. DOI: 10.1136/jnnp-2025-336597
Kaila, L.V., Ikeda, M., Sultana, J., et al. (2025). "The evolving therapeutic landscape of dementia with Lewy bodies." The Lancet Neurology 24(12): 1038-1052. DOI: 10.1016/S1474-4422(25)00323-0
Baun, A.M., Firbank, M., Hinz, R., et al. (2025). "[11C](R)-PK11195 Positron Emission Tomography Imaging of Skull Inflammation in Isolated Rapid-Eye-Movement Sleep Behavior Disorder." MOVEMENT DISORDERS (in press). DOI: 10.1002/mds.70133
Vasili, E., König, A., Al-Azzani, M., et al. (2025). "Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses." npj Parkinson's Disease 11(1): 307. DOI: 10.1038/s41531-025-01159-w
Harrison, J.R., Tang, S.L., Burston, B., et al. (2025). "Large Language Models: A Paradigm Shift for Dementia Diagnosis and Care." British Journal of Hospital Medicine: 1-19. DOI: 10.12968/hmed.2024.0666
Colloby, S.J., McAleese, K.E., Walker, L., et al. (2025). "Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer's disease and synucleinopathies." BRAIN 148(5): 1562-1576.DOI: 10.1093/brain/awae372
Donaghy, P.C., Hasoon, J., Hamilton, C.A., et al. (2025). "Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies." MOVEMENT DISORDERS 40(6): 1200-1205.DOI: 10.1002/mds.30181
Erskine, D. and Taylor, J.P. (2025). "Current strategies in the management of dementia with Lewy bodies and future directions based on disease pathophysiology." MOLECULAR NEURODEGENERATION 20(1).DOI: 10.1186/s13024-025-00856-7
Espay, A.J., Lees, A.J., Cardoso, F., et al. (2025). "The α-synuclein seed amplification assay: Interpreting a test of Parkinson's pathology." PARKINSONISM & RELATED DISORDERS 131.DOI: 10.1016/j.parkreldis.2024.107256
Firbank, M.J., Donaghy, P.C., Allan, L.M., et al. (2025). "Changes in DTI-ALPS index and its associations with neuronal damage in Lewy body disease." PARKINSONISM & RELATED DISORDERS 140.DOI: 10.1016/j.parkreldis.2025.108014
Goldman, J.G., Boeve, B.F., Galasko, D., et al. (2025). "Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies." ALZHEIMERS & DEMENTIA 21(7).DOI: 10.1002/alz.70470
Hamilton, C.A., Donaghy, P.C., Taylor, J.P., et al. (2025). "Progression of clinical diagnostic features and cognitive decline in mild cognitive impairment with Lewy bodies." PSYCHOLOGICAL MEDICINE 55.DOI: 10.1017/S0033291725100895
Hamilton, C.A., Donaghy, P.C., Taylor, J.P., et al. (2025). "Cross-sectional and longitudinal associations between depressive symptoms and cognitive performance in mild cognitive impairment." BRITISH JOURNAL OF PSYCHIATRY.DOI: 10.1192/bjp.2025.10341
Harrison, J., Colloby, S., O'Brien, J., et al. (2025). "A Spatial Covariance 1235IA-85380 SPECT Study of α4β2 Nicotinic Receptors in Dementia with Lewy Bodies." BJPSYCH OPEN 11: S37-S37.DOI: 10.1192/bjo.2025.10131
Kane, J.P.M., Fitzpatrick, R.L., Betzhold, S., et al. (2025). "A common outcome set for trials in dementia with Lewy bodies (DLB COS)." ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS 11(3).DOI: 10.1002/trc2.70134
Koss, D.J., Todd, O., Menon, H., et al. (2025). "A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies." MOLECULAR NEURODEGENERATION 20(1).DOI: 10.1186/s13024-025-00813-4
Morgan, K.D., Collerton, D., Firbank, M.J., et al. (2025). "Visual cortical activity in Charles Bonnet syndrome: testing the deafferentation hypothesis." JOURNAL OF NEUROLOGY 272(3).DOI: 10.1007/s00415-024-12741-2
Poole, M., Killen, A. and Robinson, L. (2025). "A multi-stakeholder evaluation of a walking football group for people with dementia developed in partnership with a premier league club." Sports 13(6): 172.DOI: 10.3390/sports13060172
Tang, S.L., Robertson, A., Liang, H.Z., et al. (2025). "LUMEN: Prototype Conversational AI to Streamline Dementia Assessments." BJPSYCH OPEN 11: S16-S16.DOI: 10.1192/bjo.2025.10185
Wright, L.M., Donaghy, P.C., Burn, D.J., et al. (2025). "Brain network connectivity underlying neuropsychiatric symptoms in prodromal Lewy body dementia." NEUROBIOLOGY OF AGING 151: 95-106.DOI: 10.1016/j.neurobiolaging.2025.04.007
Greenfinch, G., et al. (2024). "Longitudinal changes in cardiac mIBG scintigraphy in mild cognitive impairment with Lewy bodies." BJPSYCH OPEN 10(6).DOI: 10.1192/bjo.2024.766
Hamilton, C.A., et al. (2024). "Associations between multimorbidity and neuropathology in dementia: consideration of functional cognitive disorders, psychiatric illness and dementia mimics." BRITISH JOURNAL OF PSYCHIATRY 224(6): 237-244.DOI: 10.1192/bjp.2024.25
Walker, L. and J. Attems (2024). "Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms." JOURNAL OF PARKINSONS DISEASE 14(1): 35-52.DOI: 10.3233/JPD-230154
Walker, L., et al. (2024). "Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease." ACTA NEUROPATHOLOGICA COMMUNICATIONS 12(1).DOI: 10.1186/s40478-023-01714-7
Full list of publications, many of them as Open Access, can be downloaded from Newcastle University ePrints service.
Just click on any of our group members to see a full list of publications.
Google Sites
Report abuse